Biocryst Pharmaceuticals reported $218.43M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alnylam Pharmaceuticals ALNY:US $ 745.77M 366.22M
Biocryst Pharmaceuticals BCRX:US $ 218.43M 8.47M
Chemocentryx CCXI:US $ 77.2M 8.66M
Chugai Pharma 4519:JP Y 187131M 25082M
Daiichi Sankyo 4568:JP Y 352262M 28285M
Enanta Pharmaceuticals ENTA:US $ 4.6M 72.53M
Gilead Sciences GILD:US $ 7361M 3296M
Glaxosmithkline GSK:US $ 3503M 1254M
GlaxoSmithKline GSK:LN 3503M 1254M
Intra Cellular Therapies ITCI:US $ 121.03M 8.95M
IONIS PHARMACEUT IONS:US $ 565.12M 150.96M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Mirati Therapeutics MRTX:US $ 258.99M 35.9M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Novavax NVAX:US $ 238.03M 4.68M
Ptc Therapeutics PTCT:US $ 177.35M 30.72M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Ultragenyx Pharmaceutical RARE:US $ 290.88M 92.92M
Vertex Pharmaceuticals VRTX:US $ 6063.68M 240.65M
YTE INCY:US $ 1797.58M 127.61M
Zogenix ZGNX:US $ 77.33M 38.36M